On 19 January, the EPAD consortium elected to use AnalytiXagility as its data and analytics platform. AnalytiXagility belongs to Scottish clinical and translational informatics company Aridhia. The platform combines analytical, collaboration and audit tools to support and accelerate data-driven projects. It will be accessible to all of the consortium partners, and is able to carry…
What is your current role in EPAD? I’m currently working full time as project manager for Janssen on the IMI-EPAD project. My main role, as member of the EPAD Project Management office and WP5, is to provide overall management to the project including supporting the coordinator in liaising with IMI, work plan & schedule control,…
What is your current role in EPAD? I’m the International Coordinator for WP4 (EPAD cohort and proof of concept studies) based at the University of Edinburgh with Professor Craig Ritchie. I also represent WP4 on the Clinical Development Group as the Operational Manager. The roles involve working with the Trial Delivery Centres to get them…
January 15th marked the first anniversary of the official launch of the European Prevention of Alzheimer’s Dementia (EPAD) Initiative in Paris. To celebrate turning one, we look back at some of our key achievements of the past 12 months. March On 19 March, the Innovative Medicines Initiative (IMI) launched its Alzheimer’s Disease Research Platform, with…
Development of interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzheimer’s Dementia (EPAD) project Summary Alzheimer’s dementia affects more than 40 million people worldwide with substantial increases in prevalence anticipated. Interventions that either modify risk or reduce the development of early disease could delay the onset of dementia or reduce the…
On 2 December 2015, members of Alzheimer Europe’s European Working Group of People with Dementia (EWGPWD) and their carers took part in a consultation for the European Prevention of Alzheimer’s Dementia (EPAD) study. Lead researcher Professor Craig Ritchie, Edinburgh University, set the scene with an excellent presentation of the EPAD project, covering the aims and…
On 3, 5 and 6 November 2015, four EPAD focus groups were conducted in Barcelona. These groups are part of a larger research project led by the University of Cambridge. The focus groups’ research aims at providing insights into how understandings of Alzheimer’s disease risk and its implications are shaped by cultural, social and economic conditions,…
On October 14th 2015, Craig Ritchie gave the Wicking Trust Public Lecture in Melbourne which is attended by various representatives of leading research bodies, policy think tanks, care providers, consumers and carers. One of his primary goals while there is to share information about EPAD and hopefully enlist support and involvement in the EPAD project…
On 15 October 2015, EPAD’s Luc Truyen, Vice-President, Neuroscience External Affairs, Janssen R&D (pictured here, with Princess Anne), along with the University of Edinburgh team, represented the EPAD consortium at a University event to launch the new offices for the Centre for Clinical Brain Sciences. They had the honour of introducing the project to Her…
21 September 2015 –The European Prevention of Alzheimer’s Dementia Consortium (EPAD), a project co-funded by the Innovative Medicines Initiative (IMI) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), announces today the official launch of www.ep-ad.org. The EPAD website is devoted to inform different audiences including the scientific community, companies, people with dementia, families…
